Teeft.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration H2N2 - Exploration (Accueil)

Index « Teeft.i » - entrée « Mutant »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mutagens < Mutant < Mutant cells  Facettes :

List of bibliographic references indexed by Mutant

Number of relevant bibliographic references: 115.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000B12 (2012) Lanying Du [États-Unis] ; Ye Li [États-Unis, République populaire de Chine] ; Jimin Gao [République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Shibo Jiang [États-Unis, République populaire de Chine]Potential strategies and biosafety protocols used for dual‐use research on highly pathogenic influenza viruses
000D13 (2011) Thomas Han [États-Unis] ; Wayne A. Marasco [États-Unis]Structural basis of influenza virus neutralization
000F62 (2010) A. C. Marriott [Royaume-Uni] ; N. J. Dimmock [Royaume-Uni]Defective interfering viruses and their potential as antiviral agents
001180 (2009) Payel Das [États-Unis] ; Jingyuan Li [États-Unis] ; Ajay K. Royyuru [États-Unis] ; Ruhong Zhou [États-Unis]Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity
001332 (2008) Beixing Liu [Japon, République populaire de Chine] ; Md. Jaber Hossain [Japon] ; Isamu Mori [Japon] ; Yoshinobu Kimura [Japon]Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live‐attenuated vaccine candidate in the mouse model
001634 (2005) Derrick Louz [Pays-Bas] ; Hans E. Bergmans [Pays-Bas] ; Birgit P. Loos [Pays-Bas] ; Rob C. Hoeben [Pays-Bas]Cross‐species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live‐virus vaccines
001774 (2002) Gabriele Neumann [États-Unis] ; Yoshihiro Kawaoka [États-Unis, Japon]Generation of influenza A virus from cloned cDNAs — historical perspective and outlook for the new millenium
001775 (2002) Ralf Wagner [Allemagne] ; Mikhail Matrosovich [Allemagne, Russie] ; Hans-Dieter Klenk [Allemagne]Functional balance between haemagglutinin and neuraminidase in influenza virus infections
001858 (2001) Nadia Naffakh [France] ; Pascale Massin [France] ; Sylvie Van Der Werf [France]The Transcription/Replication Activity of the Polymerase of Influenza A Viruses Is Not Correlated with the Level of Proteolysis Induced by the PA Subunit
001884 (2001) Alexander C. Schmidt [États-Unis] ; Robert B. Couch [États-Unis] ; George J. Galasso [États-Unis] ; Frederick G. Hayden [États-Unis] ; John Mills [Australie] ; Brian R. Murphy [États-Unis] ; Robert M. Chanock [États-Unis]Current research on respiratory viral infections: Third International Symposium
001927 (2000) Irina A. Leneva [États-Unis] ; Noel Roberts [Royaume-Uni] ; Elena A. Govorkova [États-Unis] ; Olga G. Goloubeva [États-Unis] ; Robert G. Webster [États-Unis]The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses
001942 (2000) Margaret Tisdale [Royaume-Uni]Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors
001947 (2000) E. G. Brown [États-Unis]Influenza virus genetics
001953 (2000) Takahito Kashiwagi [Japon] ; Nobuyuki Hamada [Japon] ; Jun Iwahashi [Japon] ; Koyu Hara [Japon] ; Tatsuo Ueda [Japon] ; Hidetaro Noguchi [Japon] ; Tetsuya Toyoda [Japon]Emergence of New Influenza A Viruses Which Carry an Escape Mutation of the HLA‐B27‐Restricted CTL Epitope of NP in Japan
001A08 (1999) Hiroshi Kido [Japon] ; Yoshihito Beppu [Japon] ; Yasuhiro Imamura [Japon] ; Ye Chen [Japon] ; Meiko Murakami [Japon] ; Kumiko Oba [Japon] ; Takae Towatari [Japon]The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses
001A16 (1999) David A. Steinhauer [Royaume-Uni]Role of Hemagglutinin Cleavage for the Pathogenicity of Influenza Virus
001B01 (1998) Jane E. Bailly [Canada] ; Earl G. Brown [Canada]Interference by a non-defective variant of influenza A virus is due to enhanced RNA synthesis and assembly
001B02 (1998) K. A. Staschke [États-Unis] ; S. D. Hatch [États-Unis] ; J. C. Tang [États-Unis] ; W. J. Hornback [États-Unis] ; J. E. Munroe [États-Unis] ; J. M. Colacino [États-Unis] ; M. A. Muesing [États-Unis]Inhibition of Influenza Virus Hemagglutinin-Mediated Membrane Fusion by a Compound Related to Podocarpic Acid
001B04 (1998) C. Scholtissek [États-Unis] ; G. Quack [Allemagne] ; H. D Klenk [Allemagne] ; R. G Webster [États-Unis]How to overcome resistance of influenza A viruses against adamantane derivatives
001B18 (1998) Stephen S. Whitehead ; Cai-Yen Firestone ; Peter L. Collins ; Brian R. MurphyA Single Nucleotide Substitution in the Transcription Start Signal of the M2 Gene of Respiratory Syncytial Virus Vaccine Candidate cpts 248/404 Is the Major Determinant of the Temperature-Sensitive and Attenuation Phenotypes
001B30 (1997) Richard L. HodinkaWHAT CLINICIANS NEED TO KNOW ABOUT ANTIVIRAL DRUGS AND VIRAL RESISTANCE

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Mutant" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Mutant" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Mutant
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021